Dronabinol: all 178 studies that test it

Page 2 of 2. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Safety of SP-104CompletedNCT04958876Phase 1
• In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected HumansCompletedNCT04920539Phase 1
• The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated MemoriesActive, not recruitingNCT04871269Not applicable
• Do Adolescents and Adults Differ in Their Acute Response to Cannabis?CompletedNCT04851392Not applicable
• The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid ProductsCompletedNCT04741477Phase 1
• The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle GlaucomaCompletedNCT04596826Phase 2
• Reward and Drug Effects on Mood and Brain ResponseCompletedNCT04512365Early Phase 1
• Efficacy of Inhaled Cannabis for Acute Migraine TreatmentCompletedNCT04360044Phase 2
• Dronabinol for Post-operative Pain After Lumbar FusionStatus unknownNCT04346407Phase 4
• A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint ArthroplastyStatus unknownNCT04298528Phase 3
• Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy VolunteersTerminatedNCT04231643Early Phase 1
• THC and Ketamine Effects in Humans: Relation to Neural Oscillations and PsychosisCompletedNCT04199468Phase 1
• Investigating the Effect of Dronabinol on Post-surgical PainWithdrawnNCT04099355Early Phase 1
• Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 StudyCompletedNCT04080427Phase 1
• Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell DiseaseTerminatedNCT03978156Phase 1
• Evaluation of Dronabinol For Acute Pain Following Traumatic InjuryWithdrawnNCT03928015Phase 2
• The Effect of Tetrahydrocannabinol on Ocular Hemodynamics in Healthy SubjectsCompletedNCT03907163Not applicable
• Dronabinol Opioid Sparing Evaluation (DOSE) TrialStatus unknownNCT03766269Phase 2
• Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone MetsCompletedNCT03661892Early Phase 1
• A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette SyndromeStatus unknownNCT03651726Phase 2
• Cannabis Oil for Chronic Non-Cancer Pain TreatmentStatus unknownNCT03635593Phase 2
• Tetrahydrocannabinol (THC) and SleepCompletedNCT03560934Early Phase 1
• Effects of THC and Alcohol on Driving PerformanceWithdrawnNCT03555968Phase 4
• Effects of THC on Emotional Memory RetrievalCompletedNCT03471585Early Phase 1
• Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)CompletedNCT03215940Early Phase 1
• Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar DisorderTerminatedNCT03206463Phase 1
• A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette SmokingCompletedNCT02961309Phase 1
• The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial DysautonomiaWithdrawnNCT02608931Phase 2
• Comparative Bioavailability of Dronabinol Oral Solution in Healthy VolunteersCompletedNCT02604992Not applicable
• Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and PregnenoloneCompletedNCT02576912Phase 1
• Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest PainWithdrawnNCT02569073Phase 4
• Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET StudyWithdrawnNCT02492074Phase 1
• Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different CannabinoidsCompletedNCT02487381Phase 1
• Cannabinoids, Learning, and MemoryActive, not recruitingNCT02407808Phase 1
• Ethanol and Cannabinoid Effects on Simulated Driving and Related CognitionActive, not recruitingNCT02404688Phase 1
• N-acetylcysteine Effects on TetrahydrocannabinolTerminatedNCT02335060Early Phase 1
• Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food IntakeActive, not recruitingNCT02310347Not applicable
• Effects of THC and CBD on Human Episodic Memory FunctionCompletedNCT02291562Not applicable
• Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)CompletedNCT02291536Not applicable
• The Role of the Endocannabinoid System in Sweet Taste Intensity and LikingCompletedNCT02112292Not applicable
• Probing the Cannabinoid System in Individuals With a Family History of PsychosisActive, not recruitingNCT02102113Early Phase 1
• A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid UsersCompletedNCT02094599Phase 1
• Cannabinoids and Cerebellar-Motor FunctioningCompletedNCT01853020Early Phase 1
• Combined THC and CBD Drops for Treatment of Crohn's DiseaseCompletedNCT01826188Phase 1/2
• Perioperative Δ9-THC for Postsurgical PainStatus unknownNCT01790555Phase 2
• Safety and Tolerability of Namisol in the ElderlyCompletedNCT01740960Phase 1
• Delta-THC in DementiaCompletedNCT01608217Phase 2
• Cannabinoid Modulation of PainCompletedNCT01595620Early Phase 1
• The Effects of ∆-9-THC and Naloxone in HumansCompletedNCT01591629Early Phase 1
• The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal PainCompletedNCT01562483Phase 2
• Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal PainCompletedNCT01551511Phase 2
• Neuroprotection by Cannabinoids in Huntington's DiseaseCompletedNCT01502046Phase 2
• Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting ConditionsCompletedNCT01448772Phase 1
• Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting ConditionsCompletedNCT01380457Phase 1
• Efficacy Study of Δ9-THC to Treat Chronic Abdominal PainCompletedNCT01318369Phase 2
• Delta-THC in Behavioral Disturbances in DementiaCompletedNCT01302340Phase 2
• The Effects of Cannabidiol and ∆-9-THC in HumansCompletedNCT01180374Early Phase 1
• Efficacy Trial of Oral Tetrahydrocannabinol in Patients With FibromyalgiaStatus unknownNCT01149018Not applicable
• Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationCompletedNCT01037608Phase 1
• Effects of Delta-9-THC and Iomazenil in Healthy HumansCompletedNCT00982982Early Phase 1
• Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)Status unknownNCT00965809Phase 4
• Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple SclerosisCompletedNCT00959218Phase 3
• Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00812851Not applicable
• Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia NervosaCompletedNCT00760695Phase 3
• Cannabinoids, Neural Synchrony, and Information ProcessingCompletedNCT00708994Early Phase 1
• Pharmacogenetics of Cannabinoid ResponseCompletedNCT00678730Early Phase 1
• Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingCompletedNCT00642512Phase 3
• Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNCT00642499Phase 2
• Investigating the Acute Effects of THC on Functional Brain SystemsCompletedNCT00628706Phase 1
• Cannabinoid Receptor Function & AlcoholismCompletedNCT00624715Phase 1
• Ph1 Marinol Interaction Study - Part 1 - 1TerminatedNCT00438139Phase 1
• Efficacy of Dronabinol for the Treatment of Cervical DystoniaStatus unknownNCT00418925Phase 2
• Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)Status unknownNCT00377468Phase 2
• Effect of Lofexidine and Oral THC on Marijuana Withdrawal and RelapseCompletedNCT00373503Phase 2
• Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot StudyCompletedNCT00316563Phase 2
• Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic PainCompletedNCT00153192Phase 2/3
• Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDSCompletedNCT00079560Phase 1/2
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1

← Dronabinol overview